12 August 2003 CJD Update Latest facts, figures & findings Jonathan P Clewley TSE Unit, Virus Reference Division, Centre for Infections 20 May 2005.

Slides:



Advertisements
Similar presentations
Overview Nature of the infectious particle in TSE TSE strains
Advertisements

Distinctive characteristics
Defective Interfering RNAs DI RNAs are formed by deletion and recombination during viral RNA replication They require helper virus to replicate and to.
1 Chapter 50 Molecular Basis of Prion Diseases Copyright © 2012, American Society for Neurochemistry. Published by Elsevier Inc. All rights reserved.
Prion Disease Transmissible spongiform encephalopathy (TSE)
Removal of Prions by Plasma Fractionation Processes
CJD Overview Bob Will, National CJD Surveillance Unit, Edinburgh, UK Associazione Italiana Encefalopatie da Prion Milano 3 Ottobre 2009.
Prions MICR 401 Group 8: Ben Saiyasombat 10/30/2012 Department of Biology and Microbiology.
PRIONS Defn: small proteinaceous infectious particles that resist inactivation by procedures that modify viruses and nucleic acids.
Are humans susceptible?
Presumptive Transfusion Transmissions of vCJD: Introduction to Consideration of Current FDA-recommended Safeguards FDA TSE Advisory Committee 16 th Meeting.
Mouse Prion Protein Domain PrP( ) Andreas Razen Geometric Computations in Molecular Biology 2 May 2007.
Osman Adil Jamshed Chem th December, Prions Prions are misfolded form of proteins classified as infectious pathogens. Responsible for fatal.
1 Transmissible Spongiform Encephalopathies. 2 Kuru Since the early 1900’s the Fore people of New Guinea have honored their dead by cooking and consuming.
Transmissible Spongiform Encephalopathies (Prion disorders)
Bovine Spongiform Encephalopathy Luke VanNatter Carrie Pell Amy Richwine Scott Inskeep Kristina Anderson.
Prions Fact or Science Fiction?. Stanley Prusiner, 1982 Born in Des Moines, Ia. Suggested that spongiform encephalopathies in animals and humans are caused.
Prions Alicia Arguelles, Jerry Wang May 4, What are prions? proteinaceous infectious particle an infectious agent made only of protein, containing.
Mad Cow Disease. Effects of Mad Cow disease Mad cow disease, or bovine spongiform encephalopathy (BSE), is a fatal brain disorder that occurs in cattle.
CLINICAL ASPECTS OF BIOCHEMISTRY NEURODEGENERATIVE DISEASES Prion diseases Alzheimer's disease.
© Elsevier, 2011.Principles of Molecular Virology Subviral Agents Satellites and viroids – parasites of parasites! Prions - infectious protein molecules.
Disorders caused by pathological conformation of proteins
Prion Diseases Microbes and Society Fall What is a Prion? Prion- small proteinaceous infectious particles which resist inactivation by procedures.
Creutzfelt-Jacob Disease (CJD)
Evolution of the Mad Cow Disease in the United States Denish Moorthy, Eugene Shubnikov, Ron LaPorte The Supercourse Network of the Global Health University.
Holly Allen CREUTZFELDT-JAKOB DISEASE.  Human equivalent of mad cow disease  Rare, degenerative, fatal disease  Approximately 1 case per million per.
BIOCHEMISTRY DR AMENA RAHIM. Structure of Elastin It is a connective tissue protein Rubber like properties Elastin & glycoprotein microfibrils are present.
Transmissible Spongiform Encephalopathies (TSEs) a.k.a. Prion Diseases Transmissible  can be spread Spongiform  resembling a sponge Encephalopathies.
Transmissible Spongiform Encephalopathy Prion Protein Diseases Lisa Kennedy, Dylan Bradford, Madi Hoagland Henefield, Anders Ohman Advisor: Dr. Todd Livdahl.
Prions: Proteins Gone Bad
By : Amirah nu’aimi Sharifah Nurul Hanim TASK 2 – DISCUSS THE EXAMPLE OF PROTEIN FOLDING DISEASE BY STATING THE MECHANISM.
Fondazione IRCCS – Istituto Neurologico “Carlo Besta” Milano Gerstmann-Sträussler-Scheinker disease Fabrizio Tagliavini.
PRIONS PETER H. RUSSELL, BVSc, PhD, FRCPath, MRCVS Department of Pathology and Infectious Diseases, The Royal Veterinary College, Royal College Street,
1 An Introduction to the Viruses. 2 Viral Components All viruses have capsids- protein coats that enclose & protect their nucleic acid Viruses may have.
Protein Misfolding Can Have Deadly Consequences Yu Tiantian Li Yihan.
PRIONS Kalina Estrada TA: Yu-Chen Hwang Thursday, 7-8pm.
Proposed algorithm for approval of human TSE tests in Europe.
Chronic Wasting Disease (CWD) David Litts. What is it? Prions (infectious incomplete protein) Prions (infectious incomplete protein) Creutzfeldt-jakob.
Removal of Infectious Prions from Red Cell Concentrates Samuel Coker, PhD Principal Scientist and Technical Director Pall Medical Transmissible Spongiform.
 Foreign Sources of Infection To − Vi Nguyen. Foreign Infection  Preventable environmental source of infection  Remove infectious material, epidemic.
1 Laboratory of Bacterial, Parasitic and Unconventional Agents (LBPUA) Research Programs Report to BPAC 13 July 2006 Site Visit by Ad Hoc Review Committee.
John Gray, Sandor Dudas and Stefanie Czub
Taylor Goldbeck.  Professor and Head of Neuropathology at Yale- Department of Surgery and Faculty of Neurosciences and Virology  Focuses on dementia.
19 September 2006 Gaithersburg, MD David Peretz M.Sc., D.Sc. Senior Scientist CHIRON Submission To FDA TSE Advisory Committee Meeting.
Prion cell tropism significantly varies among animal species, depending on both the agent strain and host-specific factors. For example, prions show high.
C B E R E R Vostal 10/2005 Labeling Claims for TSE Reduction Studies with Blood Processing Filters Jaro Vostal, M.D., Ph.D. Division of Hematology, OBRR.
Proteins as Pathogens Stanley B. Prusiner, MD The Nobel Prize in Physiology or Medicine Presented by Shannon S. Rickner-Schmidt.
PRIONS 221.
The Seprion Separation System Development of a feasible blood screening protocol for abnormal prion protein Stuart Wilson Microsens Biotechnologies.
The History of Chronic Wasting Disease Dr. Trent Bollinger, CCWHC One World, One Health Symposium Sept. 29, 2004.
Removal of Infectious Prions from Red Cell Concentrates Blood Safety Advisory Committee March 17, 2005 Joseph Cervia, M.D., FACP,FAAP Professor of Clinical.
Beyond Viruses…Beyond Viroids…
Prions “Scrapie” “mad cow disease” Nobel Prize 1997
Microbes and Diseases Chapter 02. CREUTZFELDT-JAKOB DISEASE Prion.
VCJD World situation and Updates RG Will National CJD Research and Surveillance Unit Edinburgh, UK TSEAC meeting 1 st August 2011.
TOPIC II Potential Screening Assays to Detect Blood and Plasma Donors Infected with TSE Agents: Possible Criteria for Validation Pedro Piccardo, MD LBPUA,
Aya Murakami. Background Transmissible Spongiform Encephalopathies and Prion Other for TSEs CWD Distribution in the US Symptoms and Diagnosis Biomarkers.
VIRUSES and THEIR RELATIVES VIRUSES and THEIR RELATIVES.
Today’s Lecture: Bringing the disease to YOU! From the 1950s to NOW From Papua New Guinea to the U.S.A.
Prion diseases (transmissible spongiform encephalopathies) Dr. Mohammad Shakeeb, MD Specialist in clinical pathology/Microbiology and immunology.
(Bovine spongiform encephalopathy)
Rabies virus and Prion Dongli Pan
Brain Trust Chapt 22: Origins
Chronic Wasting Disease
In Vitro Generation of Infectious Scrapie Prions
PRIONS.
Volume 368, Issue 9552, Pages (December 2006)
Nat. Rev. Neurol. doi: /nrneurol
Deadly Conformations—Protein Misfolding in Prion Disease
Presentation transcript:

12 August 2003 CJD Update Latest facts, figures & findings Jonathan P Clewley TSE Unit, Virus Reference Division, Centre for Infections 20 May 2005

Transmissible spongiform encephalopathies & prions Key Points 1. How we got to where we are ­the BSE epidemic 2. The prion hypothesis 3. The prion protein: PrP C and PrP Sc 4. Secondary spread of CJD ­The number of future cases? 5. Tests for BSE and CJD

12 August Introduction How we got to where we are: the BSE epidemic

Prevalence of neurodegenerative disorders worldwide

What are the transmissible spongiform encephalopathies (TSEs)? Animal Scrapie (sheep), BSE (cattle), CWD (deer), TME (mice), FSE (cats) Human Creutzfeldt-Jakob Disease: sporadic, familial, iatrogenic, variant Gerstmann-Sträussler-Scheinker syndrome (GSS)

From BSE, early 1980s to vCJD, early 2000s

Origin of the BSE epidemic : Change in rendering process for production of cattle feed meat & bone meal (heat & solvents down) either BSE came from sheep scrapie or BSE came from sporadic cattle TSE whichever Subsequent recycling of BSE via feed

12 August The prion hypothesis The prion protein: PrP C and PrP Sc

Prion concepts Proteinaceous infective particle that lacks nucleic acid Pr otein + i nfectious + on Underlie inherited as well as communicable diseases Abnormal prions (PrP Sc ) convert normal ones (PrP C ) by shape shifting Prusiner, Sci Am, 1995

Summary of differences between normal & abnormal prions Normal PrP (30-40 kDa) Referred to as PrP C, PrP sen Sensitive to proteases, detergents Consists mostly of alpha-helix and loops, monomeric Non-infectious, cell surface glycoprotein, function? Many cells & tissues Coded by PRNP Abnormal PrP (27-30 kDa) Referred to as PrP Sc, PrP CJD, PrP res Relatively resistant to proteinase K, detergents Consists mostly of ß-sheet, polymeric, forms amyloid Isoform of PrP C, infectious, involved in pathogenesis CNS, spleen, lymph nodes Coded by PRNP

Normal cellular PrP Normal PrP C PrP C protein PrP C in cell membrane

Structures of normal and abnormal PrP Normal - PrP C Abnormal - PrP Sc, monomeric Abnormal - PrP Sc, trimeric Abnormal PrP Sc fibrils

Protein conversion of alpha PrP C to beta PrP Sc

Weismann, 2002 Models for the conversion of PrP C to PrP Sc

12 August Secondary spread of CJD: The number of future cases? Tests for BSE and CJD

149 vCJD deaths ­How many more cases? By statistics, epidemic is declining By tissue surveys, thousands incubating disease Codon 129 M/V genotype Secondary spread of vCJD ­Blood transfusion, surgery, sex? other? The need for ante-mortem diagnostic tests for CJD infection

Codon 129 M/V polymorphisms (%)

Evidence for transfusion (& other) transmission of vCJD Wilson & Ricketts Lancet ‘04 Level of EvidenceEvidenceYear Biological modelsOral transmission1996 Prions in lymphoid tissue1997 Animal evidenceMouse model1998 Sheep transfusion2000 BSE to primates2004 Case reportsHuman transmission2004 Cohort studies etc.None ----

Blood transfusion acquired vCJD & preclinical vCJD Of 48 people who received blood from 15 donors who went on to develop vCJD: Case 1 Recipient died of vCJD 7.5 years after donation Donor developed vCJD 10 years after donation Case 2 Donor died of vCJD 2 years after donation Recipient died of an anuerysm (not CJD) 5 years after donation On autopsy, evidence of PrP res in spleen Patient was M/V at codon 129 of PRNP Both were non-leucodepleted donations Llewelyn et al, 2004; Peden et al, 2004

vCJD diagnostic problems Diagnosis is by clinical criteria, & by western blotting & immunohistochemistry at PM There are no known preclinical serological or PCR markers of infection

As there are EIAs for animal TSEs, why aren’t there any for CJD? Western blots & EIAs for BSE, scrapie and CWD from Enfer, Bio-Rad, Iddex & Prionics, typically use brain stem & obex homogenates But Animals are killed or already dead WB/EIA up to a billion times less sensitive than PCR

What laboratory diagnostic tests are there for CJD? Western blot ELISA, DELFIA, CDI (in development) Capillary electrophoresis?? Immunopathology: detection of PrP Sc in brain, tonsil, appendix Surrogate markers: protein; various mRNAs (e.g. EDRF); molecular profiles in blood by Fourier transform infrared spectroscopy

Towards the development of a pre-mortem EIA for CJD Detection of PrP Sc Use proteinase K (to remove PrP C ) & a sensitive reporter system e.g. DELFIA, FCS, immuno-PCR, tadpoles Use little or no proteinase K but use denaturation to distinguish PrP C and PrP Sc ­the conformational dependent immunoassay (CDI) Capture aggregates of PrP Sc (amyloid fibrils) Protein misfolding cyclic amplification (PMCA) PrP Sc specific antibodies

Why is it hard to get antibodies that can distingush between PrP C and PrP Sc ? Antibodies do not distinguish between PrP C and PrP Sc PrP C and PrP Sc have the same amino acid composition PrP Sc is aggregated, of low immunogenicity and has few exposed specific epitopes PrP C is present at high levels in the body ­& so may swamp antibody recognition of PrP Sc

What sensitivity is needed for PrP CJD detection e.g. compared with HBsAg EIA? HBV sAg MW = 25,476 Da, 226 aa PrP MW = 21,000 Da, 208 aa HBsAg assays Can detect down to 0.1 ng/ml (if 75 ul serum added to assay = 7.5 pg = 10 7 molecules) Prion infectivity 5 fg = molecules in vitro Therefore, >1,000 increase in sensitivity of EIAs needed for PrP CJD detection

Finally: Important points & key messages 149 vCJD deaths ­How many more cases? In UK? (tonsil archive at HPA may help answer this), VV & MV cases? Elsewhere? 649 other CJD deaths Diagnosis is by clinical criteria & at post-mortem There are commercial in vitro laboratory diagnostic tests for BSE, CWD and scrapie, but none for CJD ­The animal tests are after death ­There is no test for asymptomatic disease applicable to blood vCJD may be transmissible by blood i.e. secondary cases? Can other animal TSEs cause human disease? ­Atypical scrapie, is BSE in sheep, BASE, CWD? Pathological prion protein (PrP Sc /PrP CJD ) is found in muscle What are the prospects for treatment?

12 August 2003 The End Thank you for listening

Outstanding question? Is abnormal PrP the transmissible agent? Irradiation target size too small for a virus; no virus found Amyloid fibrils induce polymerisation of precursors PrP-sen to PrP-res in vitro Infectivity in vitro ? No disease in PrP-null mice Genetic & infectious PrP mutations Over-expression of mutant PrP in transgenic mice causes disease Could be a small virus; prion strains Amyloid diseases not transmissible by fibrils No infectivity in vitro ? PrP merely a co-factor in PrP-null mice Retroviruses are genetic & infectious No transmission or +ve WB in transgenic mice Caughey & Chesebro, 1997 For Against

Histology and immunohistochemistry of a vCJD case Haematoxylin & eosinAnti-PrP antibody & haematoxylin Cortex Ironside & Head, 2004 Spleen Anti-PrP antibody & haematoxylin Tonsil

PrP res analysis of spleen by western blot Peden et al, 2004

Surgical incidents reported to the CJD incidents panel CDR May 2005

NHS trusts sending tonsils to the NATA CDR May 2005

Tonsils collected for the NATA CDR May 2005